Business Update

Corgenix announces establishment of bioterrorism defense development program

Published in TB and Outbreaks Week, February 22nd, 2005

Corgenix Medical Corp. (CONX) announced the establishment of a program to develop a rapid detection system for viral hemorrhagic fevers, a disease category recognized and classified for its risk as potential agents of bioterrorism.

Viral hemorrhagic fevers are included in the high-priority "Category A" of biological diseases as defined by the U.S. Centers for Disease Control and Prevention. Along with anthrax, botulism, plague, smallpox, and tularemia, viruses causing hemorrhagic fevers have been identified as key targets in the effort to understand and combat potential agents of bioterrorism.

In commenting about this new initiative in bioterrorism...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2005-02-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry